Literature DB >> 21503690

Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy.

Massimiliano Filosto1, Mauro Scarpelli, Paola Tonin, Silvia Testi, Maria Sofia Cotelli, Mara Rossi, Andrea Salvi, Alberto Grottolo, Valentina Vielmi, Alice Todeschini, Gian Maria Fabrizi, Alessandro Padovani, Giuliano Tomelleri.   

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder caused by mutations in the gene encoding thymidine phosphorylase and is characterized by external ophthalmoparesis, gastrointestinal dysmotility, leukoencephalopathy, and neuropathy. The availability of new therapeutic options (peritoneal dialysis, allogeneic stem cell transplantation, enzyme replacement) makes it necessary to diagnose the disease early, which is not always achieved due to the difficulty in recognizing this disorder, especially in case of atypical presentation. We describe three MNGIE patients with atypical onset of the disease. In the first patient the main symptoms were long-standing chronic fever, recurrent acute migrant arthritis, and gastrointestinal disorders mimicking autoimmune or inflammatory intestinal diseases; the second patient complained only of exercise intolerance and muscle cramps, and the third patient had a CIDP-like polyneuropathy. This study stresses the insidious heterogeneous clinical onset of some cases of MNGIE, expands the spectrum of the phenotype, and suggests considering MNGIE in the differential diagnosis of enteropathic arthritis, isolated exercise intolerance, and inflammatory polyneuropathies not responsive to the usual treatment. A better understanding of the clinical heterogeneity of MNGIE is necessary in order to diagnose atypical cases and promote early diagnosis, which is now absolutely necessary in view of the new available therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503690     DOI: 10.1007/s10545-011-9332-6

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

Review 1.  Current options in the treatment of mitochondrial diseases.

Authors:  Mauro Scarpelli; Maria Sofia Cotelli; Michelangelo Mancuso; Giuliano Tomelleri; Paola Tonin; Carla Baronchelli; Valentina Vielmi; Valeria Gregorelli; Alice Todeschini; Alessandro Padovani; Massimiliano Filosto
Journal:  Recent Pat CNS Drug Discov       Date:  2010-11

2.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): case report with a new mutation.

Authors:  Zeren Bariş; Tuba Eminoğlu; Buket Dalgiç; Leyla Tümer; Alev Hasanoğlu
Journal:  Eur J Pediatr       Date:  2010-06-29       Impact factor: 3.183

3.  Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation.

Authors:  F J Carod-Artal; M D Herrero; M C Lara; E López-Gallardo; E Ruiz-Pesini; R Martí; J Montoya
Journal:  Eur J Neurol       Date:  2007-05       Impact factor: 6.089

4.  Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis.

Authors:  Halûk Yavuz; Ahmet Ozel; Mette Christensen; Ernst Christensen; Marianne Schwartz; Mithat Elmaci; John Vissing
Journal:  Arch Neurol       Date:  2007-03

5.  Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation.

Authors:  Gérard Said; Catherine Lacroix; Violaine Planté-Bordeneuve; Bernard Messing; Abdelhamid Slama; Pascal Crenn; Annie Nivelon-Chevallier; Laurent Bedenne; Pierre Soichot; E Manceau; Daniel Rigaud; Anne Guiochon-Mantel; Claude Matuchansky
Journal:  J Neurol       Date:  2005-03-07       Impact factor: 4.849

6.  Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays.

Authors:  Ramon Martí; Antonella Spinazzola; Saba Tadesse; Ichizo Nishino; Yutaka Nishigaki; Michio Hirano
Journal:  Clin Chem       Date:  2003-11-18       Impact factor: 8.327

7.  Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency.

Authors:  Yutaka Nishigaki; Ramon Martí; William C Copeland; Michio Hirano
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

8.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder.

Authors:  I Nishino; A Spinazzola; M Hirano
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

Review 9.  Enteropathic arthritis.

Authors:  Wendy Holden; Tim Orchard; Paul Wordsworth
Journal:  Rheum Dis Clin North Am       Date:  2003-08       Impact factor: 2.670

10.  Mitochondrial neurogastrointestinal encephalomyopathy mimicking anorexia nervosa.

Authors:  Berend Feddersen; Larissa DE LA Fontaine; Jörn Oliver Sass; Jurgen Lutz; Angela Abicht; Thomas Klopstock; Ishwar Chander Verma; Eva Meisenzahl; Oliver Pogarell
Journal:  Am J Psychiatry       Date:  2009-04       Impact factor: 18.112

View more
  16 in total

1.  ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy.

Authors:  Roberto D'Angelo; Rita Rinaldi; Valerio Carelli; Elisa Boschetti; Leonardo Caporali; Mariantonietta Capristo; Carlo Casali; Giovanna Cenacchi; Laura Ludovica Gramegna; Raffaele Lodi; Antonio Daniele Pinna; Loris Pironi; Marta Stanzani; Caterina Tonon; Roberto D'Alessandro; Roberto De Giorgio
Journal:  Neurol Sci       Date:  2016-03-23       Impact factor: 3.307

2.  Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Paola Tonin; Giovanna Lucchini; Fabio Pavan; Francesca Santus; Rossella Parini; Maria Alice Donati; Maria Sofia Cotelli; Valentina Vielmi; Alice Todeschini; Francesco Canonico; Giuliano Tomelleri; Alessandro Padovani; Attilio Rovelli
Journal:  J Neurol       Date:  2012-06-19       Impact factor: 4.849

3.  The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Mauro Scarpelli; Giuseppe Kenneth Ricciardi; Alberto Beltramello; Isabella Zocca; Francesca Calabria; Anna Russignan; Francesca Zappini; Maria Sofia Cotelli; Alessandro Padovani; Giuliano Tomelleri; Massimiliano Filosto; Paola Tonin
Journal:  Neuroradiol J       Date:  2013-11-07

4.  Clinical and biochemical improvements in a patient with MNGIE following enzyme replacement.

Authors:  Bridget E Bax; Murray D Bain; Mauro Scarpelli; Massimiliano Filosto; Paola Tonin; Nicholas Moran
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

Review 5.  Gastrointestinal motility disorders in neurologic disease.

Authors:  Michael Camilleri
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

6.  The clinical eye.

Authors:  Fabrizio Elia; Michele Covella; Mariaelena Perna; Franco Aprà; Vincenzo Crupi
Journal:  Intern Emerg Med       Date:  2017-08-16       Impact factor: 5.472

Review 7.  Mitochondrial diseases: advances and issues.

Authors:  Mauro Scarpelli; Alice Todeschini; Irene Volonghi; Alessandro Padovani; Massimiliano Filosto
Journal:  Appl Clin Genet       Date:  2017-02-15

8.  Mitochondrial Sensorineural Hearing Loss: A Retrospective Study and a Description of Cochlear Implantation in a MELAS Patient.

Authors:  Mauro Scarpelli; Francesca Zappini; Massimiliano Filosto; Anna Russignan; Paola Tonin; Giuliano Tomelleri
Journal:  Genet Res Int       Date:  2012-02-20

Review 9.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network.

Authors:  Michio Hirano; Valerio Carelli; Roberto De Giorgio; Loris Pironi; Anna Accarino; Giovanna Cenacchi; Roberto D'Alessandro; Massimiliano Filosto; Ramon Martí; Francesco Nonino; Antonio Daniele Pinna; Elisa Baldin; Bridget Elizabeth Bax; Alessio Bolletta; Riccardo Bolletta; Elisa Boschetti; Matteo Cescon; Roberto D'Angelo; Maria Teresa Dotti; Carla Giordano; Laura Ludovica Gramegna; Michelle Levene; Raffaele Lodi; Hanna Mandel; Maria Cristina Morelli; Olimpia Musumeci; Alessia Pugliese; Mauro Scarpelli; Antonio Siniscalchi; Antonella Spinazzola; Galit Tal; Javier Torres-Torronteras; Luca Vignatelli; Irina Zaidman; Heinz Zoller; Rita Rinaldi; Massimo Zeviani
Journal:  J Inherit Metab Dis       Date:  2020-09-08       Impact factor: 4.750

10.  Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a Novel TYMP Mutation: The Need for Early Diagnosis.

Authors:  Mauro Scarpelli; Anna Russignan; Melinda Zombor; Csaba Bereczki; Francesca Zappini; Romina Buono; Bridget E Bax; Alessandro Padovani; Paola Tonin; Massimiliano Filosto
Journal:  Case Rep Neurol       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.